Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats

scientific journal article

Spinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1471-4159.2008.05429.X
P3181OpenCitations bibliographic resource ID488658
P698PubMed publication ID18419759
P5875ResearchGate publication ID5432446

P50authorWilliam RostèneQ28872703
Stéphane Mélik ParsadaniantzQ56512551
Nicolas BeaudetQ57561132
P2093author name stringPhilippe Sarret
Marc-André Dansereau
Patrick Kitabgi
Michel Pohl
Annie Mauborgne
Blandine Pommier
Romain-Daniel Gosselin
Patricia Mechighel
P2860cites workInterleukin-8 as a mediator of sympathetic painQ35871781
Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.Q40364641
Characterization of a novel chemokine-containing storage granule in endothelial cells: evidence for preferential exocytosis mediated by protein kinase A and diacylglycerolQ46740233
P433issue2
P407language of work or nameEnglishQ1860
P1104number of pages13
P304page(s)757-769
P577publication date2008-04-17
P1433published inJournal of NeurochemistryQ6295643
P1476titleSpinal CCL2 pronociceptive action is no longer effective in CCR2 receptor antagonist-treated rats
P478volume106

Reverse relations

cites work (P2860)
Q52728066Activation of Astrocytes and Microglial Cells and CCL2/CCR2 Upregulation in the Dorsolateral and Ventrolateral Nuclei of Periaqueductal Gray and Rostral Ventromedial Medulla Following Different Types of Sciatic Nerve Injury.
Q47389897Age-related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal in male Wistar rats.
Q44340800Altered expression of glial markers, chemokines, and opioid receptors in the spinal cord of type 2 diabetic monkeys
Q41469051Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain
Q36309229CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis
Q39279011CCL2 released at tumoral level contributes to the hyperalgesia evoked by intratibial inoculation of NCTC 2472 but not B16-F10 cells in mice
Q54378064CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury.
Q97524671CCL2/CCR2 system in neuroepithelial radial glia progenitor cells: involvement in stimulatory, sexually dimorphic effects of maternal ethanol on embryonic development of hypothalamic peptide neurons
Q48187127CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy
Q89961859CX3CR1 contributes to streptozotocin-induced mechanical allodynia in the mouse spinal cord
Q36082738Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain
Q42159792Chemokine CCL2 modulation of neuronal excitability and synaptic transmission in rat hippocampal slices
Q37323999Chemokine action in the nervous system
Q37507494Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons
Q37215729Chemokines and pain mechanisms.
Q39227824Chemokines in neuron-glial cell interaction and pathogenesis of neuropathic pain.
Q37684327Chemokines, neuronal-glial interactions, and central processing of neuropathic pain
Q91699852Coadministration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats
Q33866116Contribution of the chemokine (C-C motif) ligand 2 (CCL2) to mechanical hypersensitivity after surgical incision in rats
Q46297733DNA damage mediates changes in neuronal sensitivity induced by the inflammatory mediators, MCP-1 and LPS, and can be reversed by enhancing the DNA repair function of APE1.
Q92642853Development of chronic pain in males with traumatic spinal cord injury: role of circulating levels of the chemokines CCL2 and CXCL10 in subacute stage
Q47298502Ethanol and Cytokines in the Central Nervous System
Q35122783Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia
Q52571505Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice.
Q37051472Expression and function of CCL2/CCR2 in rat micturition reflexes and somatic sensitivity with urinary bladder inflammation
Q84092189Extracellular matrix proteoglycan plays a pivotal role in sensitization by low pH of mechanosensitive currents in nociceptive sensory neurones
Q37115195Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development
Q36122082Human axonal survival of motor neuron (a-SMN) protein stimulates axon growth, cell motility, C-C motif ligand 2 (CCL2), and insulin-like growth factor-1 (IGF1) production
Q64896004Hypothalamic CCL2/CCR2 Chemokine System: Role in Sexually Dimorphic Effects of Maternal Ethanol Exposure on Melanin-Concentrating Hormone and Behavior in Adolescent Offspring.
Q44031587Implication of the chemokine CCL2 in trigeminal nociception and traumatic neuropathic orofacial pain.
Q37442704Influence of the vanilloid receptor TRPV1 on the activation of spinal cord glia in mouse models of pain
Q33965479Insights into the regulation of chemokine receptors by molecular signaling pathways: functional roles in neuropathic pain
Q42155319Interferon-gamma potentiates NMDA receptor signaling in spinal dorsal horn neurons via microglia-neuron interaction
Q91703368Interferon-γ facilitates the synaptic transmission between primary afferent C-fibres and lamina I neurons in the rat spinal dorsal horn via microglia activation
Q39079653Involvement of spinal chemokine CCL2 in the hyperalgesia evoked by bone cancer in mice: a role for astroglia and microglia
Q37194288JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain
Q31126222Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).
Q90719812Macrophage biology in the peripheral nervous system after injury
Q37420652Microglia and neuropathic pain
Q41786321Minocycline, a microglial inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of glutamatergic transmission in substantia gelatinosa neurons
Q28582114NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9
Q37896669Neurochemokines: a menage a trois providing new insights on the functions of chemokines in the central nervous system.
Q26864449Neuroendocrine immunoregulation in multiple sclerosis
Q38167771Neuropathic pain and cytokines: current perspectives
Q64966538Nuclear factor kappa B regulated monocyte chemoattractant protein-1/chemokine CC motif receptor-2 expressing in spinal cord contributes to the maintenance of cancer-induced bone pain in rats.
Q38318330Opioid and chemokine receptor crosstalk: a promising target for pain therapy?
Q40842430PKC-NF-κB are involved in CCL2-induced Nav1.8 expression and channel function in dorsal root ganglion neurons
Q37080681Paeoniflorin and Albiflorin Attenuate Neuropathic Pain via MAPK Pathway in Chronic Constriction Injury Rats
Q36639036Pain in experimental autoimmune encephalitis: a comparative study between different mouse models
Q35860828Pannexin-1 Up-regulation in the Dorsal Root Ganglion Contributes to Neuropathic Pain Development
Q24646738Pathological and protective roles of glia in chronic pain
Q33925677Pathological pain and the neuroimmune interface
Q99724582Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain
Q38246264Peroxisome proliferator-activated receptor agonists modulate neuropathic pain: a link to chemokines?
Q35561030Sciatic nerve injury induces functional pro-nociceptive chemokine receptors in bladder-associated primary afferent neurons in the rat
Q90712908Spinal IL-36γ/IL-36R participates in the maintenance of chronic inflammatory pain through astroglial JNK pathway
Q91914143Spinal mechanisms of neuropathic pain: Is there a P2X4-BDNF controversy?
Q35168721Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators
Q34113663Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344
Q89210678Sustained stimulation of β2- and β3-adrenergic receptors leads to persistent functional pain and neuroinflammation
Q97075152The Delayed-Onset Mechanical Pain Behavior Induced by Infant Peripheral Nerve Injury Is Accompanied by Sympathetic Sprouting in the Dorsal Root Ganglion
Q64892118The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.
Q46133545The chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a Gβγ-dependent mechanism
Q37677143The role(s) of cytokines/chemokines in urinary bladder inflammation and dysfunction
Q39038441The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain
Q36717118Upregulation of nuclear factor of activated T-cells by nerve injury contributes to development of neuropathic pain
Q30500291Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain
Q47877991WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms

Search more.